Tag:
EvaMist
Latest Headlines
Latest Headlines
Vivus in line for $140M payday on EvaMist approval
Just months after licensing EvaMist from Vivus, KV Pharmaceutical announced that the FDA has approved the therapy for the treatment of menopausal symptoms. Vivus is positioned to earn a $140 million
